HealthStream Announces Second Quarter 2026 Results

(Moderate)

(Positive)

Key Terms

adjusted ebitda financial

Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.

non-gaap financial measure financial

A non-GAAP financial measure is a way companies present their financial results that excludes certain expenses or income to show how they believe their core business is performing. It matters because it can give a clearer picture of how the company is really doing, but it can also be used to make results look better than they actually are.

asc 606 technical

A U.S. accounting standard that sets consistent rules for when and how companies record revenue from contracts with customers, focusing on the transfer of promised goods or services. It matters to investors because it affects the timing and amount of reported sales and profit—like deciding whether a contractor can count payment when a job starts, progresses, or finishes—so it improves comparability and helps assess a company's true economic performance.

rule 10b5-1 regulatory

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

08/03/2026 - 04:30 PM

NASHVILLE, Tenn.--(BUSINESS WIRE)-- HealthStream, Inc. (the "Company") (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, today announced results for the second quarter ended June 30, 2026.

Second Quarter 2026

Revenues of $83.7 million, up 12.5% from $74.4 million in the second quarter of 2025, setting a new Company record for quarterly revenue
Operating income of $8.3 million, up 41.4% from $5.9 million in the second quarter of 2025
Net income of $6.7 million, up 23.8% from $5.4 million in the second quarter of 2025
Earnings per share (EPS) of $0.23 per share (diluted), up from $0.18 per share (diluted) in the second quarter of 2025
Adjusted EBITDA¹ of $20.6 million, up 16.9% from $17.6 million in the second quarter of 2025
Board of Directors declared a quarterly cash dividend of $0.035 per share, payable on August 28, 2026 to holders of record on August 17, 2026

¹ Adjusted EBITDA is a non-GAAP financial measure. A reconciliation of adjusted EBITDA to net income and disclosure regarding why we believe adjusted EBITDA provides useful information to investors is included later in this release.

Financial Results:

Second Quarter 2026 Compared to Second Quarter 2025

Revenues for the second quarter of 2026 increased by $9.3 million, or 12.5%, to $83.7 million, compared to $74.4 million for the second quarter of 2025. Subscription revenues increased by $8.0 million, or 11.2%, and professional services revenues increased by $1.3 million compared to the second quarter of 2025. Compared to the second quarter of 2025, revenue growth for the second quarter of 2026 was positively impacted by $3.1 million from our acquisitions of Virsys12 and MissionCare Collective completed during the fourth quarter of 2025 and $6.2 million from growth across our existing portfolio of solutions, of which $2.0 million related to the resolution of previously constrained estimates of variable consideration under a customer contract, which was recognized as a cumulative catch-up in accordance with ASC 606 during the second quarter of 2026.

Operating income was $8.3 million for the second quarter of 2026, up 41.4% from $5.9 million in the second quarter of 2025. The improvement in operating income was primarily attributable to increased revenues and income associated with our sublease that commenced during the second quarter of 2025. These improvements were partially offset by higher expenses in the second quarter of 2026 including increased personnel costs, third-party software expenses, sales commissions, marketing, cloud hosting, royalties, and amortization expense from our fourth quarter 2025 acquisitions.

Net income was $6.7 million in the second quarter of 2026, up 23.8% from $5.4 million in the second quarter of 2025, and EPS was $0.23 per share (diluted) in the second quarter of 2026, up from $0.18 per share (diluted) in the second quarter of 2025.

Adjusted EBITDA was $20.6 million for the second quarter of 2026, up 16.9% from $17.6 million in the second quarter of 2025.

At June 30, 2026, the Company had cash, cash equivalents, and marketable securities of $66.7 million. The Company does not have any outstanding indebtedness from borrowed money. Capital expenditures incurred during the second quarter of 2026 were $8.5 million.

Year-to-Date 2026 Compared to Year-to-Date 2025

For the six months ended June 30, 2026, revenues were $164.9 million, an increase of 11.5% over revenues of $147.9 million for the first six months of 2025. Operating income for the first six months of 2026 increased by 54.2% to $15.8 million, compared to $10.3 million for the first six months of 2025. The increase in operating income was primarily attributable to higher revenues and income associated with our sublease that commenced during the second quarter of 2025, partially offset by higher expenses to support investments in several areas of the business, primarily in our platform and enterprise applications, resulting in higher labor costs, third-party software, royalties expense, cloud hosting, along with higher commissions expense. Net income for the first six months of 2026 increased to $12.6 million, compared to $9.7 million for the first six months of 2025. Earnings per share were $0.43 per share (diluted) for the first six months of 2026, compared to $0.32 per share (diluted) for the first six months of 2025. Adjusted EBITDA increased by 20.4% to $40.7 million for the first six months of 2026, compared to $33.8 million for the first six months of 2025.

Other Business Updates

On March 13, 2026, the Company announced a new share repurchase program approved by the Board of Directors under which the Company is authorized to repurchase up to $10.0 million of its outstanding shares of common stock. Pursuant to this authorization, the Company is authorized to make repurchases in the open market, including under Rule 10b5-1 plans, through privately negotiated transactions, or otherwise. This share repurchase program will terminate on the earlier of September 12, 2026 or when the maximum dollar amount under the plan is expended. During the three months ended June 30, 2026, the Company repurchased 90,131 shares of common stock at an aggregate fair value of $1.8 million under this authorization. Moreover, during the six months ended June 30, 2026, the Company repurchased 209,498 shares of common stock at an aggregate fair value of $4.3 million under this authorization.

Additionally, during the three months ended March 31, 2026, the Company repurchased 222,978 shares of common stock at an aggregate fair value of $5.0 million under its prior share repurchase program that was authorized on November 11, 2025. This program authorized the Company to repurchase up to $10.0 million of its outstanding shares of common stock and terminated during the three months ended March 31, 2026 when the maximum dollar amount under the program was expended.

In the aggregate during the first six months of 2026, the Company repurchased 432,476 shares of common stock under the share repurchase programs described above on a collective basis at an aggregate fair value of $9.3 million, reflecting an average purchase of $21.50 per share (excluding the cost of broker commissions and the 1% share repurchase excise tax imposed by the Inflation Reduction Act of 2022).

On August 3, 2026, the Board of Directors approved a quarterly cash dividend under the Company's dividend policy of $0.035 per share, payable on August 28, 2026 to holders of record on August 17, 2026.

Financial Outlook for 2026

The Company is updating its guidance for 2026 for the measures set forth below.

	Full Year 2026 Guidance
		Low			High
Revenue¹	$	327.0	-	$	332.0	million

Net Income²	$	19.5	-	$	22.2	million

Adjusted EBITDA³	$	74.0	-	$	78.0	million

Capital Expenditures	$	31.0	-	$	34.0	million

¹Previous expected Revenue guidance range was $323.0 to $330.0 million.

²Previous expected Net Income guidance range was $20.4 to $22.8 million.

³ Previous expected Adjusted EBITDA guidance range was $73.0 to $77.0 million. Adjusted EBITDA is a non-GAAP financial measure. A reconciliation of projected adjusted EBITDA to projected net income (the most comparable GAAP measure) is included later in this release.

The Company’s guidance for 2026, as set forth above, reflects the Company’s assumptions regarding, among other things, expectations for new sales and renewals, and assumes that general economic conditions do not deteriorate. This guidance does not include the impact of any future acquisitions or dispositions that we may complete during 2026, gains or losses from changes in the fair value of non-marketable equity investments or contingent consideration, or impairment of long-lived assets.

Robert A. Frist, Jr., Chief Executive Officer, HealthStream, said, "In the second quarter of 2026, HealthStream delivered record revenue of $83.7 million, up 12.5%, and adjusted EBITDA of $20.6 million, up 16.9%, compared to the second quarter of 2025. This performance gives us the flexibility to continue investing in our hStream platform and products that we believe will drive durable, long-term growth as we build an even stronger ecosystem for the healthcare organizations and professionals we serve."

A conference call with Robert A. Frist, Jr., Chief Executive Officer, Scott A. Roberts, Chief Financial Officer and Senior Vice President, and Mollie Condra, Head, Investor Relations and Communications, will be held on Tuesday, August 4, 2026, at 9:00 a.m. (ET). Participants may access the conference call live via webcast using this link: https://edge.media-server.com/mmc/p/jzehvmr3. To participate via telephone, please register in advance using this link: https://register-conf.media-server.com/register/BIe2f962877acd428995d6691d8adf91a5. A replay of the conference call and webcast will be archived on the Company’s website in the Investor Relations section under “Events & Presentations.”

Use of Non-GAAP Financial Measures

This press release presents adjusted EBITDA, a non-GAAP financial measure used by management in analyzing the Company’s financial results and ongoing operational performance. In order to better assess the Company’s financial results, management believes that net income before interest, income taxes, stock-based compensation, depreciation and amortization, impairments of long-lived assets, changes in fair value of contingent consideration, and changes in fair value of, including gains (losses) on the sale of, non-marketable equity investments (“adjusted EBITDA”) is a useful measure for evaluating the operating performance of the Company because adjusted EBITDA reflects net income adjusted for certain GAAP accounting, non-cash, and/or non-operating items which may not, in any such case, fully reflect the underlying operating performance of our business. We believe that adjusted EBITDA is useful to investors to assess the Company’s ongoing operating performance and to compare the Company’s operating performance between periods. In addition, certain short-term cash incentive bonuses and performance-based equity awards are based on the achievement of adjusted EBITDA (as defined in applicable bonus and equity grant documentation) targets.

Adjusted EBITDA is a non-GAAP financial measure and should not be considered as a measure of financial performance under GAAP. Because adjusted EBITDA is not a measurement determined in accordance with GAAP, adjusted EBITDA is susceptible to varying calculations. Accordingly, adjusted EBITDA, as presented, may not be comparable to other similarly titled measures of other companies and has limitations as an analytical tool.

Adjusted EBITDA should not be considered a substitute for, or superior to, measures of financial performance, which are prepared in accordance with GAAP. Investors are encouraged to review the reconciliations of adjusted EBITDA to net income (the most comparable GAAP measure), which is set forth below in this release.

About HealthStream

HealthStream (Nasdaq: HSTM) is the healthcare industry’s largest ecosystem of platform-delivered clinical workforce solutions that empowers healthcare professionals to do what they do best: deliver excellence in patient care. For more information about HealthStream, visit www.healthstream.com or call 615-301-3100.

HEALTHSTREAM, INC. Condensed Consolidated Statements of Income (In thousands, except per share data) (Unaudited)

	Three Months Ended					Six Months Ended
	June 30, 2026			June 30, 2025		June 30, 2026			June 30, 2025
Revenues, net	$	83,732		$	74,396	$	164,935		$	147,881
Operating costs and expenses:
Cost of revenues (excluding depreciation and amortization)		29,015			26,364		56,774			51,851
Product development		13,581			12,073		27,187			24,121
Sales and marketing		13,503			11,808		26,463			23,958
General and administrative		8,037			7,398		16,039			16,066
Depreciation and amortization		11,275			10,867		22,640			21,621
Total operating costs and expenses		75,411			68,510		149,103			137,617

Operating income		8,321			5,886		15,832			10,264

Interest income		475			958		889			1,889
Other (expense) income, net		(100	)		23		(204	)		(39	)

Income before income tax provision		8,696			6,867		16,517			12,114
Income tax provision		2,027			1,478		3,938			2,393
Net income	$	6,669		$	5,389	$	12,579		$	9,721

Net income per share:
Basic	$	0.23		$	0.18	$	0.43		$	0.32
Diluted	$	0.23		$	0.18	$	0.43		$	0.32

Weighted average shares of common stock outstanding:
Basic		29,230			30,320		29,303			30,382
Diluted		29,314			30,450		29,369			30,519
Dividends declared per share	$	0.035		$	0.031	$	0.070		$	0.062

HEALTHSTREAM, INC. Condensed Consolidated Balance Sheets (In thousands) (Unaudited)

	June 30,			December 31,
	2026			2025
ASSETS
Current assets:
Cash and cash equivalents	$	46,169		$	36,161
Marketable securities		20,562			20,843
Accounts and unbilled receivables, net		36,803			38,998
Prepaid and other current assets		26,687			23,654
Total current assets		130,221			119,656

Capitalized software development, net		46,638			45,581
Property and equipment, net		10,169			10,661
Operating lease right of use assets, net		13,818			15,272
Goodwill and intangible assets, net		272,697			282,448
Other assets		48,056			46,756
Total assets	$	521,599		$	520,374

LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable, accrued, and other liabilities	$	29,653		$	35,729
Deferred revenue		92,983			88,417
Total current liabilities		122,636			124,146
Deferred tax liabilities		21,952			18,246
Deferred revenue, noncurrent		1,452			1,344
Operating lease liability, noncurrent		13,429			14,684
Other long-term liabilities		5,525			7,931
Total liabilities		164,994			166,351

Shareholders’ equity:
Common stock		224,384			231,797
Accumulated other comprehensive loss		(1,890	)		(1,361	)
Retained earnings		134,111			123,587
Total shareholders’ equity		356,605			354,023
Total liabilities and shareholders' equity	$	521,599		$	520,374

HEALTHSTREAM, INC. Condensed Consolidated Statements of Cash Flows (In thousands) (Unaudited)

	Six Months Ended
	June 30,			June 30,
	2026			2025
Operating activities:
Net income	$	12,579		$	9,721
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		22,640			21,621
Stock-based compensation		2,415			1,940
Amortization of deferred commissions		6,872			6,017
Deferred income taxes		3,724			467
Provision for credit losses		222			391
Loss on equity method investments		66			107
Other		(356	)		(776	)
Changes in assets and liabilities:
Accounts and unbilled receivables		1,944			3,465
Prepaid and other assets		(8,640	)		(10,324	)
Accounts payable, accrued, and other liabilities		(5,512	)		(4,224	)
Deferred revenue		4,613			3,692
Net cash provided by operating activities		40,567			32,097

Investing activities:
Cash paid for acquisitions		(312	)		—
Proceeds (purchases) from marketable securities, net		607			(27	)
Purchase of other investments		(2,600	)		(500	)
Purchases of property and equipment		(1,650	)		(3,372	)
Payments associated with capitalized software development		(14,251	)		(14,500	)
Net cash used in investing activities		(18,206	)		(18,399	)

Financing activities:
Taxes paid related to net settlement of equity awards		(582	)		(1,075	)
Payment of earn-outs related to acquisitions		(401	)		—
Payment of cash dividends		(2,055	)		(1,890	)
Repurchases of common stock		(9,306	)		(18,121	)
Net cash used in financing activities		(12,344	)		(21,086	)

Effect of exchange rate changes on cash and cash equivalents		(9	)		21
Net increase (decrease) in cash and cash equivalents		10,008			(7,367	)
Cash and cash equivalents at beginning of period		36,161			59,469
Cash and cash equivalents at end of period	$	46,169		$	52,102

Reconciliation of GAAP to Non-GAAP Financial Measures⁽¹⁾ Operating Results Summary (In thousands) (Unaudited)

	Three Months Ended June 30,						Six Months Ended June 30,
	2026			2025			2026			2025
GAAP net income	$	6,669		$	5,389		$	12,579		$	9,721
Interest income		(475	)		(958	)		(889	)		(1,889	)
Interest expense		25			25			50			50
Income tax provision		2,027			1,478			3,938			2,393
Stock-based compensation expense		1,106			836			2,415			1,940
Depreciation and amortization		11,275			10,867			22,640			21,621
Fair value adjustment on contingent consideration		(4	)		—			(4	)		—
Adjusted EBITDA	$	20,623		$	17,637		$	40,729		$	33,836

⁽¹⁾ This press release presents adjusted EBITDA, which is a non-GAAP financial measure used by management in analyzing its financial results and ongoing operational performance.

Reconciliation of GAAP to Non-GAAP Financial Measures Financial Outlook for 2026 (In thousands) (Unaudited)

	Low			High
Net income	$	19,500		$	22,200
Interest income		(1,600	)		(1,800	)
Interest expense		100			100
Income tax provision		6,100			7,000
Stock-based compensation expense		4,600			4,800
Depreciation and amortization		45,300			45,700
Adjusted EBITDA	$	74,000		$	78,000

This press release includes certain forward-looking statements (statements other than solely with respect to historical fact), including statements regarding expectations for financial performance for 2026 and our quarterly dividend that involve risks and uncertainties regarding HealthStream. These statements are based upon management’s beliefs, as well as assumptions made by and data currently available to management. This information has been, or in the future may be, included in reliance on the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. The Company cautions that forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements to be materially different from future results, performance, or achievements expressed or implied by the forward-looking statements, including as a result of negative economic conditions, changes in U.S. policy, adverse developments impacting the technology and healthcare industry, tariff and trade-related developments, inflationary pressures, geopolitical instability, and legal requirements and contractual restrictions which may affect the continuation of our quarterly cash dividend policy and the declaration and/or payment of dividends thereunder, which may be modified, suspended, or canceled in any manner and at any time that our Board may deem necessary or appropriate, as well as risks referenced in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed on February 26, 2026, and in the Company’s other filings with the Securities and Exchange Commission from time to time. Consequently, such forward-looking information should not be regarded as a representation or warranty or statement by the Company that such projections will be realized. Many of the factors that will determine the Company’s future results are beyond the ability of the Company to control or predict. Readers should not place undue reliance on forward-looking statements, which reflect management’s views only as of the date hereof. The Company undertakes no obligation to update or revise any such forward-looking statements.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260803745383/en/

Scott A. Roberts
Chief Financial Officer
(615) 301-3182
ir@healthstream.com

Media:
Mollie Condra, Ph.D.
Head, Investor Relations & Communications
(615) 301-3237
mollie.condra@healthstream.com

Source: HealthStream, Inc.

HealthStream Announces Second Quarter 2026 Results

Key Terms

Related Articles